Avanos Medical (AVNS) Current Assets (2013 - 2026)

Avanos Medical has disclosed Current Assets across 14 years of filings, most recently posting $325.0 million for Q1 2026.

• Current Assets for Q1 2026 came in at $325.0 million, down 7.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $325.0 million (down 7.78% YoY), and the FY2025 annual result was $355.4 million, down 9.66% from the prior year.
• Current Assets came in at $325.0 million for Q1 2026 at Avanos Medical, down from $355.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $624.1 million in Q4 2022 to a low of $325.0 million in Q1 2026.
• The 5-year median for Current Assets is $453.8 million (2023), against an average of $440.6 million.
• Across the five-year window, Current Assets jumped 45.95% in 2022 and dropped 25.65% in 2025, its largest moves.
• Avanos Medical's Current Assets stood at $624.1 million in 2022, then retreated by 21.97% to $487.0 million in 2023, then retreated by 19.22% to $393.4 million in 2024, then retreated by 9.66% to $355.4 million in 2025, then decreased by 8.55% to $325.0 million in 2026.
• The last three Current Assets figures came in at $325.0 million (Q1 2026), $355.4 million (Q4 2025), and $351.4 million (Q3 2025), per Business Quant data.